Thursday 4 August 2011

FDI in Pharma Industry in India

The recent takeovers of Indian companies by MNCs could increase the possibility of other takeovers of Indian companies which would have impact on the Indian health care scenario as well as on pricing and availability of medicines in India.

As such an appropriate assessment requires to be made. The Department of Pharmaceuticals of Government of India have requested the Department of Commerce to conduct a study on the recent takeovers of Indian Companies by the MNCs. Thereafter, the recommendation could be placed before the Economic Advisory Council to the Prime Minister or any other authority. Department of Commerce has informed that they have entrusted the task of this study to M/s Ernst & Young.

The policy of Foreign Direct Investment (FDI) in existing Indian Pharmaceutical Companies has come in for public comments especially on the issue of takeover of existing Indian Pharmaceutical companies by multi-national companies. With a view to examine the issues involved in a border perspectives, Planning Commission has with the approval of the Prime Minister of India constituted a High Level Committee (HLC) under the Chairpersonship of Mr Arun Maira, Member (Industry), Planning Commission to consider all the relevant aspects.


No comments:

Post a Comment